222 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Carlyle, SK Capital Partners disclose expected closing date of bluebird bio deal https://seekingalpha.com/news/4453950-carlyle-sk-capital-partners-disclose-expected-closing-date-of-bluebird-bio-deal?source=feed_sector_healthcare May 30, 2025 -
Instil Bio shares rise after updates on cancer trials https://seekingalpha.com/news/4451642-instil-bio-shares-rise-on-immunotherapy-trial-updates?source=feed_sector_healthcare May 22, 2025 -
BIO-key International, Inc. (BKYI) Q1 2025 Earnings Call Transcript https://seekingalpha.com/article/4787752-bio-key-international-inc-bkyi-q1-2025-earnings-call-transcript?source=feed_sector_transcripts May 16, 2025 -
Bluebird Bio Jumps In Pre-market Following Amended Acquisition Agreement https://www.rttnews.com/story.aspx?Id=3539124 May 14, 2025 - bluebird bio, Inc. (BLUE), a biotechnology company, Carlyle (CG) and SK Capital Partners, LP Wednesday said they have amended their agreement pursuant to which Carlyle and SK Capital will purchase all outstanding shares of bluebird. bluebird bio shares were more than 50% up in pre-market.
Nuvation Bio Inc. (NUVB) Q1 2025 Earnings Call Transcript https://seekingalpha.com/article/4785431-nuvation-bio-inc-nuvb-q1-2025-earnings-call-transcript?source=feed_sector_transcripts May 11, 2025 -
Entera Bio GAAP EPS of -$0.06 beats by $0.01 https://seekingalpha.com/news/4446072-entera-bio-gaap-eps-of-0_06-beats-by-0_01?source=feed_tag_israel May 09, 2025 -
Carlyle Group, SK Capital secure all regulatory approvals to acquire bluebird bio https://seekingalpha.com/news/4441277-carlyle-group-sk-capital-secure-all-regulatory-approvals-to-acquire-bluebird-bio?source=feed_sector_healthcare May 05, 2025 -
Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript https://seekingalpha.com/article/4780940-bio-rad-laboratories-inc-bio-q1-2025-earnings-call-transcript?source=feed_sector_transcripts May 01, 2025 -
INmune Bio partners with Cell and Gene Therapy Catapult https://seekingalpha.com/news/4430929-inmune-bio-partners-with-cell-and-gene-therapy-catapult?source=feed_sector_healthcare Apr 14, 2025 -
Third Harmonic Bio plans to liquidate the company, sell urticaria treatment https://seekingalpha.com/news/4430863-third-harmonic-bio-plans-to-liquidate-the-company-sell-urticaria-treatment?source=feed_sector_healthcare Apr 14, 2025 -

Pages: 1234567...23

<Page 2>